The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lettmann Jason since 2016.
This trader's CIK number is 1688269.
At the time of last reporting, Lettmann Jason was the CHIEF EXECUTIVE OFFICER of Alx Oncology Holdings Inc. (stock ticker symbol ALXO).
Also see all insider trading activities at Alx Oncology Holdings Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | RARX | 393,923 | $5,120,999 | 340 | $4,420 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ALXO | 0 | $0 | 4,541 | $4,006 | 0 | $0 |
| 2021 | ALXO | 0 | $0 | 471,014 | $13,789,351 | 0 | $0 |
| 2020 | ALXO | 400,000 | $7,600,000 | 0 | $0 | 0 | $0 |
1. Ra Pharmaceuticals, Inc. (RARX)
2. Alx Oncology Holdings Inc (ALXO)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-10-31 | RARX | Sale | 340 | 13.00 | 4,420 |
| 2016-10-31 | RARX | Buy | 393,923 | 13.00 | 5,120,999 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-15 | ALXO | Sale | 2,382 | .64 | 1,524 |
| 2025-02-19 | ALXO | Sale | 2,159 | 1.15 | 2,482 |
| 2021-12-13 | ALXO | Sale | 325,377 | 27.91 | 9,081,272 |
| 2021-12-08 | ALXO | Sale | 42,458 | 33.52 | 1,422,979 |
| 2021-12-10 | ALXO | Sale | 26,274 | 31.49 | 827,447 |
| 2021-12-09 | ALXO | Sale | 76,905 | 31.96 | 2,457,653 |
| 2020-07-21 | ALXO | Buy | 400,000 | 19.00 | 7,600,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lettmann Jason (CHIEF EXECUTIVE OFFICER of Alx Oncology Holdings Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.